| Rayner Eye Clinic, Llc | |
|
2606 S. Lamar Oxford MS 38655-5302 | |
| (662) 234-6551 | |
| Not Available |
| Full Name | Rayner Eye Clinic, Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 2606 S. Lamar, Oxford, Mississippi |
| Authorized Official Name and Position | William D Farmer (OWNER) |
| Authorized Official Contact | 6622346551 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Rayner Eye Clinic, Llc 1308 Belk Blvd Oxford MS 38655-5302 Ph: () - | Rayner Eye Clinic, Llc 2606 S. Lamar Oxford MS 38655-5302 Ph: (662) 234-6551 |
| NPI Number | 1326148578 |
|---|---|
| Provider Enumeration Date | 09/25/2006 |
| Last Update Date | 11/25/2022 |
| Medicare PECOS PAC ID | 9537136577 |
|---|---|
| Medicare Enrollment ID | O20040910000538 |
News Archive
Pain Therapeutics, Inc. today announced encouraging clinical data with PTI-188, an early-stage drug for metastatic melanoma. Metastatic melanoma is a lethal form of skin cancer in which patients typically have a median survival time of 9 months.
Healthcare-associated vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CD), and other multidrug-resistant organisms (MDRO) were decreased among patients after adding ultraviolet environmental disinfection (UVD) to the cleaning regimen, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Today's headlines include news regarding specific examples of what could happen at the state level if Congress doesn't extend enhanced federal Medicaid funding.
Biothera has announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326148578 | NPI | - | NPPES |
| C02819 | Other | MS | MEDICARE PTAN |
| 06350509 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
| Provider Name | Thomas M Tann |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1083654578 PECOS PAC ID: 2365410933 Enrollment ID: I20040921001034 |
News Archive
Pain Therapeutics, Inc. today announced encouraging clinical data with PTI-188, an early-stage drug for metastatic melanoma. Metastatic melanoma is a lethal form of skin cancer in which patients typically have a median survival time of 9 months.
Healthcare-associated vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CD), and other multidrug-resistant organisms (MDRO) were decreased among patients after adding ultraviolet environmental disinfection (UVD) to the cleaning regimen, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Today's headlines include news regarding specific examples of what could happen at the state level if Congress doesn't extend enhanced federal Medicaid funding.
Biothera has announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August.
› Verified 8 days ago
| Provider Name | Cliff O Blaylock |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1043259146 PECOS PAC ID: 6709838337 Enrollment ID: I20050211000421 |
News Archive
Pain Therapeutics, Inc. today announced encouraging clinical data with PTI-188, an early-stage drug for metastatic melanoma. Metastatic melanoma is a lethal form of skin cancer in which patients typically have a median survival time of 9 months.
Healthcare-associated vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CD), and other multidrug-resistant organisms (MDRO) were decreased among patients after adding ultraviolet environmental disinfection (UVD) to the cleaning regimen, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Today's headlines include news regarding specific examples of what could happen at the state level if Congress doesn't extend enhanced federal Medicaid funding.
Biothera has announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August.
› Verified 8 days ago
| Provider Name | William D Irvine |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1760488498 PECOS PAC ID: 1951381086 Enrollment ID: I20050228000418 |
News Archive
Pain Therapeutics, Inc. today announced encouraging clinical data with PTI-188, an early-stage drug for metastatic melanoma. Metastatic melanoma is a lethal form of skin cancer in which patients typically have a median survival time of 9 months.
Healthcare-associated vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CD), and other multidrug-resistant organisms (MDRO) were decreased among patients after adding ultraviolet environmental disinfection (UVD) to the cleaning regimen, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Today's headlines include news regarding specific examples of what could happen at the state level if Congress doesn't extend enhanced federal Medicaid funding.
Biothera has announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August.
› Verified 8 days ago
| Provider Name | Jorge I Calzada |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1538154117 PECOS PAC ID: 1052342516 Enrollment ID: I20061205000651 |
News Archive
Pain Therapeutics, Inc. today announced encouraging clinical data with PTI-188, an early-stage drug for metastatic melanoma. Metastatic melanoma is a lethal form of skin cancer in which patients typically have a median survival time of 9 months.
Healthcare-associated vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CD), and other multidrug-resistant organisms (MDRO) were decreased among patients after adding ultraviolet environmental disinfection (UVD) to the cleaning regimen, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Today's headlines include news regarding specific examples of what could happen at the state level if Congress doesn't extend enhanced federal Medicaid funding.
Biothera has announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August.
› Verified 8 days ago
| Provider Name | Randy Kent Richardson |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1013951987 PECOS PAC ID: 4880752252 Enrollment ID: I20081029000516 |
News Archive
Pain Therapeutics, Inc. today announced encouraging clinical data with PTI-188, an early-stage drug for metastatic melanoma. Metastatic melanoma is a lethal form of skin cancer in which patients typically have a median survival time of 9 months.
Healthcare-associated vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CD), and other multidrug-resistant organisms (MDRO) were decreased among patients after adding ultraviolet environmental disinfection (UVD) to the cleaning regimen, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Today's headlines include news regarding specific examples of what could happen at the state level if Congress doesn't extend enhanced federal Medicaid funding.
Biothera has announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August.
› Verified 8 days ago
| Provider Name | William Doty Farmer |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1902840861 PECOS PAC ID: 4385645829 Enrollment ID: I20090128000243 |
News Archive
Pain Therapeutics, Inc. today announced encouraging clinical data with PTI-188, an early-stage drug for metastatic melanoma. Metastatic melanoma is a lethal form of skin cancer in which patients typically have a median survival time of 9 months.
Healthcare-associated vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CD), and other multidrug-resistant organisms (MDRO) were decreased among patients after adding ultraviolet environmental disinfection (UVD) to the cleaning regimen, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Today's headlines include news regarding specific examples of what could happen at the state level if Congress doesn't extend enhanced federal Medicaid funding.
Biothera has announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August.
› Verified 8 days ago
| Provider Name | Jonathan T Zoghby |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1962631150 PECOS PAC ID: 2668615717 Enrollment ID: I20140612001679 |
News Archive
Pain Therapeutics, Inc. today announced encouraging clinical data with PTI-188, an early-stage drug for metastatic melanoma. Metastatic melanoma is a lethal form of skin cancer in which patients typically have a median survival time of 9 months.
Healthcare-associated vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CD), and other multidrug-resistant organisms (MDRO) were decreased among patients after adding ultraviolet environmental disinfection (UVD) to the cleaning regimen, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Today's headlines include news regarding specific examples of what could happen at the state level if Congress doesn't extend enhanced federal Medicaid funding.
Biothera has announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August.
› Verified 8 days ago
| Provider Name | Emily Graves |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1154540359 PECOS PAC ID: 0840477071 Enrollment ID: I20150926000196 |
News Archive
Pain Therapeutics, Inc. today announced encouraging clinical data with PTI-188, an early-stage drug for metastatic melanoma. Metastatic melanoma is a lethal form of skin cancer in which patients typically have a median survival time of 9 months.
Healthcare-associated vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CD), and other multidrug-resistant organisms (MDRO) were decreased among patients after adding ultraviolet environmental disinfection (UVD) to the cleaning regimen, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Today's headlines include news regarding specific examples of what could happen at the state level if Congress doesn't extend enhanced federal Medicaid funding.
Biothera has announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August.
› Verified 8 days ago
| Provider Name | Lee E Moore |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1699156950 PECOS PAC ID: 5597078394 Enrollment ID: I20200518001254 |
News Archive
Pain Therapeutics, Inc. today announced encouraging clinical data with PTI-188, an early-stage drug for metastatic melanoma. Metastatic melanoma is a lethal form of skin cancer in which patients typically have a median survival time of 9 months.
Healthcare-associated vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CD), and other multidrug-resistant organisms (MDRO) were decreased among patients after adding ultraviolet environmental disinfection (UVD) to the cleaning regimen, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Today's headlines include news regarding specific examples of what could happen at the state level if Congress doesn't extend enhanced federal Medicaid funding.
Biothera has announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August.
› Verified 8 days ago
| Provider Name | Arthur C Guyton |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1164982427 PECOS PAC ID: 5193170306 Enrollment ID: I20231009000520 |
News Archive
Pain Therapeutics, Inc. today announced encouraging clinical data with PTI-188, an early-stage drug for metastatic melanoma. Metastatic melanoma is a lethal form of skin cancer in which patients typically have a median survival time of 9 months.
Healthcare-associated vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CD), and other multidrug-resistant organisms (MDRO) were decreased among patients after adding ultraviolet environmental disinfection (UVD) to the cleaning regimen, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Today's headlines include news regarding specific examples of what could happen at the state level if Congress doesn't extend enhanced federal Medicaid funding.
Biothera has announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August.
› Verified 8 days ago
News Archive
Pain Therapeutics, Inc. today announced encouraging clinical data with PTI-188, an early-stage drug for metastatic melanoma. Metastatic melanoma is a lethal form of skin cancer in which patients typically have a median survival time of 9 months.
Healthcare-associated vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CD), and other multidrug-resistant organisms (MDRO) were decreased among patients after adding ultraviolet environmental disinfection (UVD) to the cleaning regimen, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Today's headlines include news regarding specific examples of what could happen at the state level if Congress doesn't extend enhanced federal Medicaid funding.
Biothera has announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August.
› Verified 8 days ago
Baptist Memorial Health Services Inc Of Mississippi Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2301 S Lamar Blvd, Oxford, MS 38655 Phone: 662-232-8568 Fax: 662-513-1450 | |
Onecare Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2706 W Oxford Loop Ste 103, Oxford, MS 38655 Phone: 662-414-6048 | |
Urgent Care Clinic Of Oxford Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1487 Belk Blvd, Oxford, MS 38655 Phone: 662-234-1090 Fax: 662-234-0432 | |
Athletico Ltd Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2205 Jefferson Davis Dr, Oxford, MS 38655 Phone: 662-238-2800 Fax: 662-238-2808 | |
North Mississippi Primary Health Care, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2716 W Oxford Loop Ste 171, Oxford, MS 38655 Phone: 662-224-8951 Fax: 662-224-6801 | |
North Mississippi Family Medicine Group Of Oxford Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1397 Belk Blvd, Oxford, MS 38655 Phone: 662-236-4675 Fax: 662-281-0819 | |
Gastroenterology Associates Of North Ms Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1208 Office Park Dr, Oxford, MS 38655 Phone: 662-234-9888 Fax: 662-281-8927 |